• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸化CREB1蛋白水平升高与透明细胞肾细胞癌的不良预后相关。

Increased phosphorylated CREB1 protein correlates with poor prognosis in clear cell renal cell carcinoma.

作者信息

Zhang Zhongyuan, Guan Bao, Li Yifan, He Qun, Li Xuesong, Zhou Liqun

机构信息

Department of Urology, Peking University First Hospital, Beijing, China.

Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.

出版信息

Transl Androl Urol. 2021 Aug;10(8):3348-3357. doi: 10.21037/tau-21-371.

DOI:10.21037/tau-21-371
PMID:34532259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421817/
Abstract

BACKGROUND

This study aims to investigate the level of cAMP response element-binding protein 1 (phospho S133) (p-CREB1) protein in clear cell renal cell carcinoma (ccRCC) and evaluates its prognosis significance.

METHODS

Immunohistochemistry (IHC) method was performed to detect p-CREB1 staining in 233 ccRCC patients. Three or more high-power fields per tissue section were equally captured by a Leica DMRXA microphotographic system, and average staining intensity (optical density, OD) was analyzed by Leica Qwin Standard V2.6 system. Univariate and multivariate Cox proportional regression model was performed to assess the correlation of p-CREB1 staining and clinical outcomes.

RESULTS

IHC proved that the level of p-CREB1 protein was significantly higher in tumor tissues than in adjacent normal tissues, and gradually increased from normal to tumor sections. On the basis of the receiver operating characteristic curve, patients were divided into low p-CREB1 staining (OD ≤0.28) and high p-CREB1 staining subgroup (OD >0.28) according to p-CREB1 protein staining intensity of tumor cells. Multivariate analyses showed that high p-CREB1staining was an independent risk factor for cancer-specific free survival, overall survival and progression-free survival.

CONCLUSIONS

p-CREB1 protein is an independent prognostic biomarker for ccRCC patients.

摘要

背景

本研究旨在探讨透明细胞肾细胞癌(ccRCC)中cAMP反应元件结合蛋白1(磷酸化S133)(p-CREB1)蛋白的水平,并评估其预后意义。

方法

采用免疫组织化学(IHC)方法检测233例ccRCC患者的p-CREB1染色情况。用徕卡DMRXA显微摄影系统在每个组织切片上均匀采集三个或更多高倍视野,并用徕卡Qwin Standard V2.6系统分析平均染色强度(光密度,OD)。采用单因素和多因素Cox比例回归模型评估p-CREB1染色与临床结局的相关性。

结果

免疫组织化学证实,肿瘤组织中p-CREB1蛋白水平显著高于相邻正常组织,且从正常组织到肿瘤组织切片逐渐升高。根据肿瘤细胞的p-CREB1蛋白染色强度,基于受试者工作特征曲线将患者分为低p-CREB1染色(OD≤0.28)和高p-CREB1染色亚组(OD>0.28)。多因素分析表明,高p-CREB1染色是癌症特异性无病生存、总生存和无进展生存的独立危险因素。

结论

p-CREB1蛋白是ccRCC患者的独立预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bb/8421817/5ff198a9bf1f/tau-10-08-3348-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bb/8421817/5bcf3f4e04c7/tau-10-08-3348-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bb/8421817/ec6e6ab6b198/tau-10-08-3348-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bb/8421817/0fe780ad1bd5/tau-10-08-3348-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bb/8421817/5ff198a9bf1f/tau-10-08-3348-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bb/8421817/5bcf3f4e04c7/tau-10-08-3348-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bb/8421817/ec6e6ab6b198/tau-10-08-3348-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bb/8421817/0fe780ad1bd5/tau-10-08-3348-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29bb/8421817/5ff198a9bf1f/tau-10-08-3348-f4.jpg

相似文献

1
Increased phosphorylated CREB1 protein correlates with poor prognosis in clear cell renal cell carcinoma.磷酸化CREB1蛋白水平升高与透明细胞肾细胞癌的不良预后相关。
Transl Androl Urol. 2021 Aug;10(8):3348-3357. doi: 10.21037/tau-21-371.
2
Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.免疫组织化学染色法检测肌纤维连接蛋白在透明细胞肾细胞癌中的预后意义及其与表皮生长因子受体表达的关系。
Urol Oncol. 2019 Nov;37(11):812.e9-812.e16. doi: 10.1016/j.urolonc.2019.07.002. Epub 2019 Aug 14.
3
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.肾细胞癌中新型预后标志物的鉴定与验证
Dan Med J. 2017 Oct;64(10).
4
Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.SR-BI 的上调促进了透明细胞肾细胞癌的进展,并可作为一种预后生物标志物。
BMC Cancer. 2018 Jan 22;18(1):88. doi: 10.1186/s12885-017-3761-z.
5
Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.高尔基α-甘露糖苷酶 II 作为一种新型生物标志物预测透明细胞肾细胞癌的预后。
Oncol Res Treat. 2020;43(6):264-275. doi: 10.1159/000505931. Epub 2020 May 13.
6
Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.白细胞介素-8表达增加是透明细胞肾细胞癌预后不良的独立指标。
Tumour Biol. 2016 Apr;37(4):4523-9. doi: 10.1007/s13277-015-4158-8. Epub 2015 Oct 27.
7
Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.上调的 GSDMB 在透明细胞肾细胞癌中与免疫浸润和不良预后相关。
J Immunol Res. 2021 Dec 16;2021:7753553. doi: 10.1155/2021/7753553. eCollection 2021.
8
CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma.CREB1 受 microRNAs miR-22-3p、miR-26a-5p、miR-27a-3p 和 miR-221-3p 的影响,与肾细胞癌的不良临床病理特征相关。
Sci Rep. 2020 Apr 16;10(1):6499. doi: 10.1038/s41598-020-63403-y.
9
Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.将 HECW1 表达纳入临床指标可高度准确地评估透明细胞肾细胞癌患者的预后。
BMC Cancer. 2021 Aug 4;21(1):890. doi: 10.1186/s12885-021-08631-9.
10
Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.FBXO11 表达在透明细胞肾细胞癌患者中的流行率和预后价值。
BMC Cancer. 2019 Jun 3;19(1):534. doi: 10.1186/s12885-019-5736-8.

引用本文的文献

1
Common molecular links and therapeutic insights between type 2 diabetes and kidney cancer.2型糖尿病与肾癌之间的常见分子联系及治疗见解
PLoS One. 2025 Aug 20;20(8):e0330619. doi: 10.1371/journal.pone.0330619. eCollection 2025.
2
The Transcription Factor CREB1 Triggers the Progression of Clear Cell Renal Cell Carcinoma by Promoting CENPE Expression.转录因子CREB1通过促进CENPE表达触发透明细胞肾细胞癌进展。
J Cell Mol Med. 2025 Aug;29(15):e70773. doi: 10.1111/jcmm.70773.
3
Multi-omics profiling reveals key factors involved in Ewing sarcoma metastasis.

本文引用的文献

1
CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma.CREB1 受 microRNAs miR-22-3p、miR-26a-5p、miR-27a-3p 和 miR-221-3p 的影响,与肾细胞癌的不良临床病理特征相关。
Sci Rep. 2020 Apr 16;10(1):6499. doi: 10.1038/s41598-020-63403-y.
2
The Transcription Factor Creb is Involved in Sorafenib-Inhibited Renal Cancer Cell Proliferation, Migration and Invasion.转录因子 CREB 参与索拉非尼抑制肾癌增殖、迁移和侵袭。
Acta Pharm. 2018 Dec 1;68(4):497-506. doi: 10.2478/acph-2018-0033.
3
Cancer statistics, 2018.
多组学分析揭示了尤因肉瘤转移所涉及的关键因素。
Mol Oncol. 2025 Apr;19(4):1002-1028. doi: 10.1002/1878-0261.13788. Epub 2025 Jan 5.
4
Identification of a cancer driver gene-associated lncRNA signature for prognostic prediction and immune response evaluation in clear cell renal cell carcinoma.鉴定一种与癌症驱动基因相关的lncRNA特征用于透明细胞肾细胞癌的预后预测和免疫反应评估
Transl Cancer Res. 2024 Jul 31;13(7):3418-3436. doi: 10.21037/tcr-24-127. Epub 2024 Jul 24.
5
The CREB1 inhibitor 666-15 maintains cartilage homeostasis and mitigates osteoarthritis progression.CREB1抑制剂666-15维持软骨稳态并减轻骨关节炎进展。
Bone Joint Res. 2024 Jan 2;13(1):4-18. doi: 10.1302/2046-3758.131.BJR-2023-0016.R2.
6
Integrative analysis of deoxyribonuclease 1-like 3 as a potential biomarker in renal cell carcinoma.脱氧核糖核酸酶1样3作为肾细胞癌潜在生物标志物的综合分析
Transl Androl Urol. 2023 Aug 31;12(8):1308-1320. doi: 10.21037/tau-23-355. Epub 2023 Aug 22.
7
[Mechanism of miR-26a-5p/cAMP response element binding protein 1 molecular axis regulating osteogenic differentiation of adipose-derived mesenchymal stem cells].[微小RNA-26a-5p/环磷酸腺苷反应元件结合蛋白1分子轴调控脂肪间充质干细胞成骨分化的机制]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 May 15;37(5):615-621. doi: 10.7507/1002-1892.202211037.
8
Immunological perspective on the malignant progression of renal clear cell carcinoma.肾透明细胞癌恶性进展的免疫学视角
Ann Transl Med. 2021 Oct;9(20):1544. doi: 10.21037/atm-21-4973.
癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
4
Ectopic Phosphorylated Creb Marks Dedifferentiated Proximal Tubules in Cystic Kidney Disease.异位磷酸化的Creb标记多囊肾病中去分化的近端小管。
Am J Pathol. 2018 Jan;188(1):84-94. doi: 10.1016/j.ajpath.2017.09.015. Epub 2017 Oct 26.
5
Korean Red Ginseng Extract Enhances the Anticancer Effects of Sorafenib through Abrogation of CREB and c-Jun Activation in Renal Cell Carcinoma.高丽红参提取物通过废除肾细胞癌细胞中 CREB 和 c-Jun 的激活增强索拉非尼的抗癌作用。
Phytother Res. 2017 Jul;31(7):1078-1089. doi: 10.1002/ptr.5829. Epub 2017 May 22.
6
Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer.在肾癌中,致癌性环磷酸腺苷反应元件结合蛋白1在肿瘤抑制性miR-10b-5p和miR-363-3p缺失时过表达。
Oncol Rep. 2016 Apr;35(4):1967-78. doi: 10.3892/or.2016.4579. Epub 2016 Jan 20.
7
High expression of cAMP-responsive element-binding protein 1 (CREB1) is associated with metastasis, tumor stage and poor outcome in gastric cancer.环磷酸腺苷反应元件结合蛋白1(CREB1)的高表达与胃癌的转移、肿瘤分期及不良预后相关。
Oncotarget. 2015 Apr 30;6(12):10646-57. doi: 10.18632/oncotarget.3392.
8
CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer.CIP2A在非小细胞肺癌中调节癌症代谢和CREB磷酸化。
Mol Biosyst. 2015 Jan;11(1):105-14. doi: 10.1039/c4mb00513a. Epub 2014 Oct 17.
9
Cyclic adenosine monophosphate-responsive element-binding protein activation predicts an unfavorable prognosis in patients with hepatocellular carcinoma.环磷酸腺苷反应元件结合蛋白激活预测肝细胞癌患者预后不良。
Onco Targets Ther. 2014 May 29;7:873-9. doi: 10.2147/OTT.S63594. eCollection 2014.
10
Molecular genetics of clear-cell renal cell carcinoma.透明细胞肾细胞癌的分子遗传学
J Clin Oncol. 2014 Jun 20;32(18):1968-76. doi: 10.1200/JCO.2012.45.2003. Epub 2014 May 12.